OVID · Insider trading · 13F holders · Congress trades
Ovid Therapeutics Inc (OVID)
Who is buying and selling OVID: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 13
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $0
- Congress trades, 12 months
- 0
OVID at a glance
- No open-market insider purchases or sales of OVID were filed in the last 90 days.
- 13 13F filers hold OVID among their 50 largest positions, worth $80.8M combined. The biggest bets by portfolio weight are Ally Bridge Group (NY) LLC (2.2%), Propel Bio Management, LLC (1.6%) and Affinity Asset Advisors, LLC (1.4%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
- No member of Congress has disclosed a trade in OVID.
OVID insider trading
No open-market insider purchases or sales of OVID were filed in the last 90 days.
Who owns OVID? Hedge funds and superinvestors
13 13F filers hold OVID among their 50 largest positions, worth $80.8M combined. The biggest bets by portfolio weight are Ally Bridge Group (NY) LLC (2.2%), Propel Bio Management, LLC (1.6%) and Affinity Asset Advisors, LLC (1.4%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| Affinity Asset Advisors, LLCHedge fund | 1.4% | $27.3M | 10,144,562 | -4.6% shares | Q2 2026 |
| ADAR1 Capital Management, LLCHedge fund | 0.9% | $20.0M | 7,417,479 | +63.2% shares | Q2 2026 |
| Silverarc Capital Management, LLCHedge fund | 0.9% | $8.3M | 3,101,129 | — | Q2 2026 |
| Stempoint Capital LPHedge fund | 1.1% | $6.5M | 2,417,283 | — | Q2 2026 |
| Ikarian Capital, LLCHedge fund | 1.0% | $6.1M | 2,269,704 | -21.6% shares | Q2 2026 |
| Propel Bio Management, LLCHedge fund | 1.6% | $3.0M | 1,115,538 | +21.1% shares | Q2 2026 |
| Rosalind Advisors, Inc.Investment manager | 1.1% | $3.0M | 1,107,994 | +0.0% shares | Q2 2026 |
| Sio Capital Management, LLCHedge fund | 0.5% | $2.7M | 1,005,334 | -19.7% shares | Q2 2026 |
| Saturn V Capital Management LPHedge fund | 0.3% | $1.8M | 663,060 | -84.1% shares | Q2 2026 |
| Ally Bridge Group (NY) LLCHedge fund | 2.2% | $1.7M | 624,561 | -77.8% shares | Q2 2026 |
| Velan Capital Investment Management LPHedge fund | 0.2% | $350K | 130,000 | -18.8% shares | Q2 2026 |
| Spark Investment Management LLCHedge fund | 0.2% | $86K | 31,800 | New | Q2 2026 |
| TLS Advisors LLCHedge fund | 0.1% | $51K | 18,858 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 13). Screen OVID in the grand portfolio →
OVID stock trades by members of Congress
No member of Congress has disclosed a trade in OVID.
OVID questions and answers
Are insiders buying OVID stock?
No open-market insider purchases or sales of OVID were filed in the last 90 days.
Which hedge funds own OVID?
13 13F filers hold OVID among their 50 largest positions, worth $80.8M combined. The biggest bets by portfolio weight are Ally Bridge Group (NY) LLC (2.2%), Propel Bio Management, LLC (1.6%) and Affinity Asset Advisors, LLC (1.4%). In their latest 13Fs, 1 manager opened a new position and 2 added to one.
Has Congress traded OVID?
No member of Congress has disclosed a trade in OVID.
Who is the largest holder of OVID?
Among 13F filers, Affinity Asset Advisors, LLC reports the largest OVID position, $27.3M (10,144,562 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is Ally Bridge Group (NY) LLC's: 2.2% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.